Cargando…

Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer

Disulfidptosis, a novel form of regulated cell death (RCD) associated with metabolism, represents a promising intervention target in cancer therapy. While abnormal lncRNA expression is associated with colon cancer development, the prognostic potential and biological characteristics of disulfidptosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xiaoqian, Liao, Pan, Liu, Xiaotong, Yang, Zhenni, Wang, Yali, Zhong, Weilong, Wang, Bangmao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454603/ https://www.ncbi.nlm.nih.gov/pubmed/37629096 http://dx.doi.org/10.3390/ijms241612915

Ejemplares similares

Disulfidptosis-associated lncRNAs predict breast cancer subtypes
por: Xia, Qing, et al.
Publicado: (2023)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature
por: Yang, Zhuo, et al.
Publicado: (2023)

Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer
por: Liu, Li, et al.
Publicado: (2023)

Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs
por: Wang, Yongfeng, et al.
Publicado: (2023)

Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy
por: Xu, Danping, et al.
Publicado: (2023)

A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma
por: Dai, Xinglong, et al.
Publicado: (2022)

Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms
por: Chi, Hao, et al.
Publicado: (2023)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study
por: Chen, Xi, et al.
Publicado: (2023)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
por: Guo, Ying, et al.
Publicado: (2023)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
por: Sun, Yimin, et al.
Publicado: (2022)

Construction of a Prognostic Signature of 10 Autophagy-Related lncRNAs in Gastric Cancer
por: Wang, Wenwen, et al.
Publicado: (2022)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

The disulfidptosis-related signature predicts prognosis and immune features in glioma patients
por: Wang, Xiong, et al.
Publicado: (2023)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma
por: Hu, Gunchu, et al.
Publicado: (2023)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
por: Wang, Zhijian, et al.
Publicado: (2023)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer
por: Qin, Muping, et al.
Publicado: (2021)

A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs
por: Zhang, Li, et al.
Publicado: (2021)

Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients
por: Wu, Jie, et al.
Publicado: (2022)

Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma
por: Wei, Shi-Yao, et al.
Publicado: (2022)

Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs
por: Li, Chenyang, et al.
Publicado: (2022)

Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature
por: Wu, Yunhao, et al.
Publicado: (2023)

Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes
por: Zhao, Hongying, et al.
Publicado: (2021)

The landscape of lncRNAs in Cydia pomonella provides insights into their signatures and potential roles in transcriptional regulation
por: Xing, Longsheng, et al.
Publicado: (2021)

Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer
por: Cai, Hua-jun, et al.
Publicado: (2021)

Immune-Related lncRNAs Pairs to Construct a Novel Signature for Predicting Prognosis in Gastric Cancer
por: Bao, Tianshang, et al.
Publicado: (2022)

Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis
por: Xu, Kai, et al.
Publicado: (2023)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Transcriptomic landscape of lncRNAs in inflammatory bowel disease
por: Mirza, Aashiq H, et al.
Publicado: (2015)

Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs
por: Diao, Xiayao, et al.
Publicado: (2022)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
por: Lu, Lina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i88e56e3ndlr67f6lfo6ll0ned